Exclusive Pharma Industry 4 min read After WHO nod, Indian Patient Groups urge GLP-1 inclusion in NLEM With the WHO recommending blockbuster GLP-1 therapies such as Semaglutide and Tirzepatide as essential medicines for diabetes, patient advocates in India are urging their inclusion in the National List of Essential Medicines (NLEM) to enable state procurement, free distribution, and wider affordability
Before their cellular effects can be fully explained, more thorough studies are required to fully understand the signaling pathways affected by dual- and triagonism
2017), improve muscle mass or function in cancer patients (Fairman et al
After two years of tinkering with the chemistry, her small team finally hit on a design that worked
Hemodynamic Profile: The net result of these actions is a significant reduction in systolic and diastolic blood pressure, heart rate, stroke volume, and total peripheral resistance, while clinically preserving renal blood flow and glomerular filtration (Mitchell et al., 2005)